Center-Authored Papers

Filters: Author is O'Callaghan, Chris  [Clear All Filters]
2010
de Gramont A, Hubbard J, Shi Q, O'Connell MJ, Buyse M, Benedetti JK, Bot B, O'Callaghan C, Yothers G, Goldberg RM et al..  2010.  Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(3):460-5. Abstract
2015
Klotz L, O'Callaghan C, Ding K, Toren P, Dearnaley D, Higano CS, Horwitz E, Malone S, Goldenberg L, Gospodarowicz M et al..  2015.  Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(10):1151-6. Abstract
2016
Cheung WY, Renfro LA, Kerr D, de Gramont A, Saltz LB, Grothey A, Alberts SR, Andre T, Guthrie KA, Labianca R et al..  2016.  Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract